Osteoporosis: The Midlife Dilemma

Estrogen is crucial for bone density maintenance. Its decline accelerates bone loss, increasing the risk of osteoporosis and fractures, particularly in the hips, spine, and wrists.

Recommended Checkups: 

• Bone Density Scan (DEXA Scan): Measures bone mineral density and assesses fracture risk.

• Vitamin D and Calcium Levels: Ensures adequate levels for bone strength.

• Parathyroid Hormone (PTH) and Thyroid Function Tests: These help assess calcium metabolism and overall bone health.

Proactive health screening is designed to detect potential health problems earlier, so you have more options and potentially better outcomes. That said, here are a few additions commonly recommend for women as they enter menopause. All of these can be done through your regular ObGyn or PCP, but it’s important to understand that they are looking for disease, not imbalances that can lead to disease.

• Bone Density Test: Request a bone density scan if you have not had one by menopause or age 50.

• Blood Work: Get comprehensive blood work that goes beyond the basic CBC and chemistry panel, including vitamin D, omega 3 and 6 fatty acids, ferritin; hsCRP, homocysteine, fractionated lipid panel, uric acid; TSH, Free T4, Free T3, Reverse T3; HbA1c.

• Pelvic Exam: Even though routine pelvic exams are no longer recommended for asymptomatic women, changes related to menopause such as atrophy and lichen sclerosus, both of which can contribute to painful sex, as well as skin cancer can be detected early.

Bone health has quickly become a unifying theme among the Fall 2025 MIDLIFE CONSORTIUM - assembled by Roberta Morris (menopause coach/national educator) with clinical specialists- Dr. Robert Bard, Dr. Angela Mazza, Dr. Jess Sabrowsky and Dr. Barbara Bartlik. Osteoporosis, often silent until fracture, disproportionately affects women in menopause.  Morris (undergoing osteoporosis management herself), underscores the importance of pairing medical solutions with lifestyle interventions. She advocates for nutrition strategies, weight-bearing exercise, and awareness campaigns to ensure that women begin prevention early, long before fractures occur.

“One of the most overlooked consequences of menopause is the rapid acceleration of bone loss. Declining estrogen levels directly affect bone density, leaving women at greater risk for osteoporosis and fractures as they age", states Dr. Mazza. "Too often, these changes progress silently until a break occurs. That’s why I emphasize early screening, preventative lifestyle strategies, and a personalized approach to hormone and metabolic health. By addressing bone strength proactively—through nutrition, exercise, imaging, and integrative care—we can help women maintain resilience, mobility, and independence well into later life.” 

Dr. Bard highlighted that ultrasound technologies—once limited to breast and thyroid use—are now validated to measure bone density at the heel, offering a safe, radiation-free alternative to DEXA scans. Sabrowsky complements this with integrative options such as PEMF therapy, which shows promise in supporting bone regeneration, alongside pharmaceutical interventions like Prolia when clinically necessary.

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

 The Women’s Health Professional Network Launches a New Consortium

By Carmen Regallo-Dewitt / Graciella Davi (Women's Health Digest)

---

A VISION FOR MIDLIFE HEALTH

9/11/2025- The Women’s Health Professional Network, an initiative under the AngioInstitute, has taken its next phase in reshaping how midlife and menopause care is delivered. At the heart of this momentum is Roberta Morris, a seasoned menopause coach whose commitment to empowering women has translated into a growing ecosystem of functional medicine, advanced diagnostics, and patient-centered education.

Guided by Morris’ vision for a clinical “Dream Team,” the Network has aligned with Dr. Robert L. Bard, a renowned diagnostic imaging specialist, Dr. Angela Mazza, an integrative endocrinologist recognized for her work in thyroid health and hormonal balance, Dr. Barbara Bartlik, an integrative psychiatrist specializing in emotional wellness and sexual health, and Dr. Leslie Valle Montoya, a longevity and regenerative medicine expert focused on detoxification and functional healing. Together, this leadership team is building a foundation that unites science, technology, and compassionate care to support women through the complex challenges of midlife.

In their most recent update meeting, the team proudly welcomed Dr. Jessica Sabrowsky, a family nurse practitioner affiliated with the Northport Wellness Center. With a patient panel that largely consists of women in their 40s, 50s, and beyond, Dr. Sabrowsky’s focus on prevention, personalized treatment, and integrative modalities makes her a natural fit for the alliance.

Advocacy and Public Education

Roberta Morris’ appointment extends beyond the coordination of clinical collaboration. With networking guidance from executive director Dr. Lennard Goetze, she is actively engaged with national organizations such as the Menopause Foundation and the Bone Health & Osteoporosis Foundation, working to bring midlife education into schools, PTAs, and broader community networks.

By leveraging her policy connections in Washington, D.C., Morris aims to expand the Network by advancing clinical science as well as supporting legislative and cultural recognition of menopause as a pivotal health stage. “We need to honor the woman as she transitions through midlife, not just manage her symptoms,” Morris insists.

Thyroid Health and Endocrine Solutions

Dr. Angela Mazza, endocrinologist and associate clinical leader of the program, contributes a vital dimension to the Network. Her expertise in thyroid and hormonal science directly intersects with midlife concerns such as weight gain, fatigue, and mood changes. Through ThyroidScan™, a joint educational and diagnostic initiative with Dr. Bard, Mazza is expanding access to advanced thyroid imaging and advocating for earlier interventions.

Mazza emphasizes that “hormonal changes in midlife don’t occur in isolation. Thyroid dysfunction, adrenal fatigue, and estrogen decline are often layered together. The earlier we can intervene with precision tools and integrative protocols, the better outcomes we see for both prevention and resilience.” Her leadership brings an evidence-based framework that bridges conventional endocrine medicine with functional and lifestyle-based care.

The Role of Advanced Imaging in Midlife Health

For Dr. Bard, the role of advanced imaging in women’s health is not merely diagnostic but revolutionary. He has long been a pioneer in using ultrasound elastography, thermography, and Doppler vascular studies to provide non-invasive, real-time insight into breast, thyroid, and cardiovascular health.

“Women often don’t want mammograms, especially those with dense breasts,” Bard explained. “With advanced ultrasound and thermal imaging, we can not only detect problems without pain or radiation, but we can also show patients when nothing is wrong—which is just as powerful for peace of mind”

His recent collaborations extend beyond the U.S., including being invited to speak at McGill University’s cancer conference in Montreal about elastography for breast and thyroid conditions. For midlife patients, Bard stresses that imaging can reveal hidden thyroid fibrosis, vascular compromise, or early bone density loss before symptoms arise.

Integrative Psychiatry for Midlife Women

Dr. Barbara Bartlik, psychiatrist and integrative medicine specialist, brings nearly four decades of experience to supporting women through midlife. Her approach blends psychotherapy, lifestyle medicine, and complementary therapies, addressing not just hormonal changes but also the emotional and relational challenges that accompany menopause. She is particularly recognized for her work in sexual health, creating safe space for women—especially cancer survivors and those on endocrine therapies—to discuss intimacy and psychological well-being often overlooked in conventional care.

Dr. Bartlik’s whole-person perspective allows her to collaborate seamlessly with endocrinologists, oncologists, and imaging specialists. By weaving psychiatric care into broader treatment plans, she helps women restore balance, resilience, and vitality. Her compassionate, integrative model reflects the Consortium’s mission: to provide midlife women with care that honors the connection between mind, body, and spirit.

---

The Arrival of Dr. Jessica Sabrowsky

Dr. Jessica Sabrowsky represents the clinical front line of the consortium. Based in Northport, New York, her practice reflects a whole-person, integrative approach:

·        Preventive screenings for thyroid, menopause, and bone density issues.

·        Functional laboratory analysis to uncover root causes of fatigue, brain fog, and metabolic imbalance.

·        Therapeutic modalities including PEMF (pulsed electromagnetic field therapy) for cellular repair, hyperbaric oxygen therapy for inflammation reduction, and PRP and IV drip therapy for nutrient restoration.

·        Biomagnetism and trauma reset therapies (QNRT) to address neuro-emotional triggers that often underlie chronic symptoms.

“Every woman goes through menopause. Nobody escapes it,” Sabrowsky reflected. “The key is to begin screening and educating early. If we can catch thyroid dysfunction or osteopenia before it becomes osteoporosis, we give women the best chance at longevity and vitality”

Her case studies demonstrate the promise of this model. One midlife patient, struggling with thyroid dysfunction, gut issues, and perimenopausal symptoms, experienced dramatic improvements in energy, sleep, and hot flashes within six weeks of integrative therapy. The only remaining challenge was bone density—a reminder that osteoporosis remains one of midlife’s greatest threats.

---

The Midlife Resource Consortium

This evolving initiative has now been formally branded as the Midlife Resource Consortium, a multi-disciplinary alliance designed to expand beyond conventional medical silos. The Consortium brings together:

·        Roberta Morris – Menopause coach and advocacy leader.

·        Dr. Robert Bard – Imaging specialist, innovator in ultrasound and thermography.

·        Dr. Angela Mazza – Endocrinologist, thyroid and hormonal health authority.

·        Dr. Jessica Sabrowsky – Integrative nurse practitioner, front-line clinician for midlife patients.

·        Dr. Barbara Bartlik - Integrative Psychiatrist

·        Dr. Leslie Valle Montoya – Physician focusing on perimenopause and integrative detox strategies.

·        Diane Taibi – Hair loss analyst, complementing hormonal and nutritional support for women facing midlife-related alopecia.

·        Gina Adams – Community outreach specialist with ScalpScan, addressing hair health and midlife self-esteem.

Together, these professionals form a holistic consortium that spans imaging, endocrinology, nutrition, functional medicine, advocacy, and aesthetics.

---

A Model for the Future

Executive Director Dr. Lennard Goetze has been instrumental in coordinating this expansion. He frames the Consortium as a “one-stop collaborative for midlife health,” where patients can access integrated care while professionals share knowledge and strategies.

“The strength of this model lies in connectivity,” Goetze emphasized. “From imaging and diagnostics to advocacy and lifestyle, we are weaving together a net strong enough to catch women before they fall through the cracks of fragmented care.”

---

Conclusion: A Crusade for Midlife

The launch of the Midlife Resource Consortium signals a new era for women’s health. What began as a partnership between a menopause coach, an imaging pioneer, and an endocrinologist has now grown into a nationally connected, multi-disciplinary alliance.

By welcoming new voices like Dr. Jessica Sabrowsky and expanding into bone health, thyroid care, hair wellness, and community outreach, the Consortium is building a comprehensive roadmap for midlife women—one that emphasizes prevention, personalization, and empowerment. In the words of Roberta Morris, “This is not just a program. It’s a movement to give women the resources, respect, and resilience they deserve as they enter one of the most defining chapters of life.”

Copyright Notice
This article draft is an original work produced by the writing and editorial team of the AngioInstitute (a 501(c)(3) nonprofit organization), created exclusively for use, distribution, and publication by MENONEWS.com. All content contained herein, including written material, concepts, titles, and formatting, is the intellectual property of the AngioInstitute and is protected under United States and international copyright laws. Unauthorized reproduction, copying, distribution, transmission, or republication of any portion of this material—whether in print, digital, or any other format—is strictly prohibited without prior written permission from the copyright holder. The AngioInstitute retains full ownership of the content until and unless formally transferred in writing. This draft may not be altered, adapted, or used in derivative works without express consent. All rights reserved. For inquiries regarding usage, permissions, or content licensing, please contact the AngioInstitute directly.

EXPANDING THE FRONTIERS OF MIDLIFE CARE

 The Women’s Health Professional Network Launches a New Consortium

By Carmen Regallo-Dewitt / Graciella Davi (Women's Health Digest)

---

A VISION FOR MIDLIFE HEALTH

The Women’s Health Professional Network, an initiative under the AngioInstitute, has taken its next phase in reshaping how midlife and menopause care is delivered. At the heart of this momentum is Roberta Morris, a seasoned menopause coach whose commitment to empowering women has translated into a growing ecosystem of functional medicine, advanced diagnostics, and patient-centered education.

Guided by Morris’ vision for a clinical “Dream Team,” the Network has aligned with Dr. Robert L. Bard, a renowned diagnostic imaging specialist, Dr. Angela Mazza, an integrative endocrinologist recognized for her work in thyroid health and hormonal balance, Dr. Barbara Bartlik, an integrative psychiatrist specializing in emotional wellness and sexual health, and Dr. Leslie Valle Montoya, a longevity and regenerative medicine expert focused on detoxification and functional healing. Together, this leadership team is building a foundation that unites science, technology, and compassionate care to support women through the complex challenges of midlife.

In their most recent update meeting, the team proudly welcomed Dr. Jessica Sabrowsky, a family nurse practitioner affiliated with the Northport Wellness Center. With a patient panel that largely consists of women in their 40s, 50s, and beyond, Dr. Sabrowsky’s focus on prevention, personalized treatment, and integrative modalities makes her a natural fit for the alliance.

Advocacy and Public Education

Roberta Morris’ appointment extends beyond the coordination of clinical collaboration. With networking guidance from executive director Dr. Lennard Goetze, she is actively engaged with national organizations such as the Menopause Foundation and the Bone Health & Osteoporosis Foundation, working to bring midlife education into schools, PTAs, and broader community networks.

By leveraging her policy connections in Washington, D.C., Morris aims to expand the Network by advancing clinical science as well as supporting legislative and cultural recognition of menopause as a pivotal health stage. “We need to honor the woman as she transitions through midlife, not just manage her symptoms,” Morris insists.

Thyroid Health and Endocrine Solutions

Dr. Angela Mazza, endocrinologist and associate clinical leader of the program, contributes a vital dimension to the Network. Her expertise in thyroid and hormonal science directly intersects with midlife concerns such as weight gain, fatigue, and mood changes. Through ThyroidScan™, a joint educational and diagnostic initiative with Dr. Bard, Mazza is expanding access to advanced thyroid imaging and advocating for earlier interventions.

Mazza emphasizes that “hormonal changes in midlife don’t occur in isolation. Thyroid dysfunction, adrenal fatigue, and estrogen decline are often layered together. The earlier we can intervene with precision tools and integrative protocols, the better outcomes we see for both prevention and resilience.” Her leadership brings an evidence-based framework that bridges conventional endocrine medicine with functional and lifestyle-based care.

The Role of Advanced Imaging in Midlife Health

For Dr. Bard, the role of advanced imaging in women’s health is not merely diagnostic but revolutionary. He has long been a pioneer in using ultrasound elastography, thermography, and Doppler vascular studies to provide non-invasive, real-time insight into breast, thyroid, and cardiovascular health.

“Women often don’t want mammograms, especially those with dense breasts,” Bard explained. “With advanced ultrasound and thermal imaging, we can not only detect problems without pain or radiation, but we can also show patients when nothing is wrong—which is just as powerful for peace of mind”

His recent collaborations extend beyond the U.S., including being invited to speak at McGill University’s cancer conference in Montreal about elastography for breast and thyroid conditions. For midlife patients, Bard stresses that imaging can reveal hidden thyroid fibrosis, vascular compromise, or early bone density loss before symptoms arise.

Integrative Psychiatry for Midlife Women

Dr. Barbara Bartlik, psychiatrist and integrative medicine specialist, brings nearly four decades of experience to supporting women through midlife. Her approach blends psychotherapy, lifestyle medicine, and complementary therapies, addressing not just hormonal changes but also the emotional and relational challenges that accompany menopause. She is particularly recognized for her work in sexual health, creating safe space for women—especially cancer survivors and those on endocrine therapies—to discuss intimacy and psychological well-being often overlooked in conventional care.

Dr. Bartlik’s whole-person perspective allows her to collaborate seamlessly with endocrinologists, oncologists, and imaging specialists. By weaving psychiatric care into broader treatment plans, she helps women restore balance, resilience, and vitality. Her compassionate, integrative model reflects the Consortium’s mission: to provide midlife women with care that honors the connection between mind, body, and spirit.

---

The Arrival of Dr. Jessica Sabrowsky

Dr. Jessica Sabrowsky represents the clinical front line of the consortium. Based in Northport, New York, her practice reflects a whole-person, integrative approach:

·        Preventive screenings for thyroid, menopause, and bone density issues.

·        Functional laboratory analysis to uncover root causes of fatigue, brain fog, and metabolic imbalance.

·        Therapeutic modalities including PEMF (pulsed electromagnetic field therapy) for cellular repair, hyperbaric oxygen therapy for inflammation reduction, and PRP and IV drip therapy for nutrient restoration.

·        Biomagnetism and trauma reset therapies (QNRT) to address neuro-emotional triggers that often underlie chronic symptoms.

“Every woman goes through menopause. Nobody escapes it,” Sabrowsky reflected. “The key is to begin screening and educating early. If we can catch thyroid dysfunction or osteopenia before it becomes osteoporosis, we give women the best chance at longevity and vitality”

Her case studies demonstrate the promise of this model. One midlife patient, struggling with thyroid dysfunction, gut issues, and perimenopausal symptoms, experienced dramatic improvements in energy, sleep, and hot flashes within six weeks of integrative therapy. The only remaining challenge was bone density—a reminder that osteoporosis remains one of midlife’s greatest threats.

---

Osteoporosis: The Midlife Dilemma

Bone health has quickly become a unifying theme among Morris, Sabrowsky, and Bard. Osteoporosis, often silent until fracture, disproportionately affects women in menopause. Dr. Bard highlighted that ultrasound technologies—once limited to breast and thyroid use—are now validated to measure bone density at the heel, offering a safe, radiation-free alternative to DEXA scans.

Morris, herself managing osteoporosis, underscores the importance of pairing medical solutions with lifestyle interventions. She advocates for nutrition strategies, weight-bearing exercise, and awareness campaigns to ensure that women begin prevention early, long before fractures occur.

Sabrowsky complements this with integrative options such as PEMF therapy, which shows promise in supporting bone regeneration, alongside pharmaceutical interventions like Prolia when clinically necessary

---

The Midlife Resource Consortium

This evolving initiative has now been formally branded as the Midlife Resource Consortium, a multi-disciplinary alliance designed to expand beyond conventional medical silos. The Consortium brings together:

·        Roberta Morris – Menopause coach and advocacy leader.

·        Dr. Robert Bard – Imaging specialist, innovator in ultrasound and thermography.

·        Dr. Angela Mazza – Endocrinologist, thyroid and hormonal health authority.

·        Dr. Jessica Sabrowsky – Integrative nurse practitioner, front-line clinician for midlife patients.

·        Dr. Barbara Bartlik - Integrative Psychiatrist

·        Dr. Leslie Valle Montoya – Physician focusing on perimenopause and integrative detox strategies.

·        Diane Taibi – Hair loss analyst, complementing hormonal and nutritional support for women facing midlife-related alopecia.

·        Gina Adams – Community outreach specialist with ScalpScan, addressing hair health and midlife self-esteem.

Together, these professionals form a holistic consortium that spans imaging, endocrinology, nutrition, functional medicine, advocacy, and aesthetics.

---

A Model for the Future

Executive Director Dr. Lennard Goetze has been instrumental in coordinating this expansion. He frames the Consortium as a “one-stop collaborative for midlife health,” where patients can access integrated care while professionals share knowledge and strategies.

“The strength of this model lies in connectivity,” Goetze emphasized. “From imaging and diagnostics to advocacy and lifestyle, we are weaving together a net strong enough to catch women before they fall through the cracks of fragmented care.”

---

Conclusion: A Crusade for Midlife

The launch of the Midlife Resource Consortium signals a new era for women’s health. What began as a partnership between a menopause coach, an imaging pioneer, and an endocrinologist has now grown into a nationally connected, multi-disciplinary alliance.

By welcoming new voices like Dr. Jessica Sabrowsky and expanding into bone health, thyroid care, hair wellness, and community outreach, the Consortium is building a comprehensive roadmap for midlife women—one that emphasizes prevention, personalization, and empowerment. In the words of Roberta Morris, “This is not just a program. It’s a movement to give women the resources, respect, and resilience they deserve as they enter one of the most defining chapters of life.”

Copyright Notice
This article draft is an original work produced by the writing and editorial team of the AngioInstitute (a 501(c)(3) nonprofit organization), created exclusively for use, distribution, and publication by MENONEWS.com. All content contained herein, including written material, concepts, titles, and formatting, is the intellectual property of the AngioInstitute and is protected under United States and international copyright laws. Unauthorized reproduction, copying, distribution, transmission, or republication of any portion of this material—whether in print, digital, or any other format—is strictly prohibited without prior written permission from the copyright holder. The AngioInstitute retains full ownership of the content until and unless formally transferred in writing. This draft may not be altered, adapted, or used in derivative works without express consent. All rights reserved. For inquiries regarding usage, permissions, or content licensing, please contact the AngioInstitute directly.

Press Release: MenoScan.org National Consortium launch

FOR IMMEDIATE RELEASE
Media Relations – MENOSCAN.org
Email: editor.prevention101@gmail.com | Phone: 516.522.0777

The AngioInstitute (501c3) 121 E60th St. #6A  New York, NY 10022

www.angioinstitute.org

---

MENOSCAN.org Launches National Consortium to Advance Diagnosis, Treatment, and Legislative Action for Women’s Midlife Disorders

New York 8/12/2025 — The AngioInstitute (501c3), a nonprofit organization dedicated to advancing public health through non-invasive diagnostics and education, has launched MENOSCAN.org, a national consortium of leading medical professionals committed to transforming women’s midlife health care. Bringing together experts in diagnostic imaging, endocrinology, psychiatry, and integrative medicine, MENOSCAN is advancing clinical diagnostics, public education, and legislative advocacy to improve early detection and treatment for the many health challenges faced during perimenopause and menopause.

The national collaborative unites experts across multiple disciplines, including:

· DR. ANGELA MAZZA (FLA), endocrinologist and chief clinical advisor to THYROIDSCAN.org, known for her integrative approach to hormonal and thyroid health.

· DR. ROBERT BARD (NYC), diagnostic imaging specialist recognized for advancing non-invasive medical technologies for early disease detection and diagnostic modalities for clinical research.

·  DR. LESLIE VALLE-MONTOYA, physician and bioenergy research specialist applying advanced metabolic health protocols to support perimenopausal women, focusing on restoring balance through innovative, non-invasive therapies.

· DR. BARBARA BARTLIK, leading integrative psychiatrist addressing the intersection of mental, emotional, and physical wellness in women’s health.

Their shared goal: to “advance the needle” on identifying and treating midlife disorders in the clinical stage, where intervention can prevent long-term disability, improve quality of life, and reduce healthcare costs. “Women in midlife are often told their symptoms are ‘just part of aging,’” says Dr. Angela Mazza. “We now have the technology and clinical insight to intervene earlier, and we must make these tools available to everyone — not just those who can afford them.”

 

TARGETING THE FULL SPECTRUM OF MIDLIFE DISORDERS

MENOSCAN.org addresses the interconnected health challenges faced by women in midlife — many of which remain underdiagnosed or undertreated due to fragmented care and outdated insurance policies. The program focuses on seven critical areas:

1. Cardiovascular Disease (CVD) – the leading cause of death in women, often overlooked during the menopause transition.

2. Breast and Reproductive Health – enhanced screening and education to reduce late-stage diagnoses.

3. Osteoporosis and Bone Health – early imaging and preventive care to reduce fracture risk.

4. Cognitive Decline and Brain Health – strategies for identifying early neurological changes.

5.Hormonal & Thyroid Function – advanced diagnostics to guide more personalized treatment plans.

6. Metabolic Syndrome and Weight Gain – addressing the root causes of midlife metabolic shifts.

7. Emotional & Mental Health – integrative care for depression, anxiety, and mood instability during menopause.

---

 

FROM THE CLINIC TO THE CAPITOL: LEGISLATIVE ADVOCACY

Beyond its clinical mission, MENOSCAN.org is building a national movement to demand better access, insurance coverage, and resources for women’s health during midlife. Spearheading this effort is Dr. Lennard Goetze, executive director and founder of the Women’s Health Professional Network and the AngioInstitute (501c3).

Dr. Goetze is leading a state-by-state outreach campaign to legislators, focusing on those who have already introduced or are considering bills addressing women’s health and menopause-related care. Proposals have already been submitted in New York, New Jersey, Florida, California, and Colorado, with the goal of creating model legislation for nationwide adoption. “Our mission is to ensure that early diagnosis, advanced screening technologies, and integrative care become standard, insured, and accessible for all women — not a privilege for the few,” says Dr. Goetze. “We are meeting with lawmakers to turn this vision into enforceable policy.”

A PUBLIC HEALTH IMPERATIVE

The stakes are high. Midlife health disorders not only impact longevity and quality of life, they also carry significant economic costs, affecting workplace productivity and increasing long-term healthcare expenditures. Dr. Robert Bard underscores the urgency: “We have decades of data linking early intervention to better health outcomes, yet too many women are falling through the cracks. MENOSCAN is bridging the gap between what medicine can do and what patients actually receive.”

---

MENOSCAN.org is a collaborative platform dedicated to advancing clinical diagnostics, education, and legislative reform for midlife women’s health. By bringing together specialists in cardiology, endocrinology, psychiatry, oncology, bone health, and integrative medicine, MENOSCAN provides a multidisciplinary approach to prevention, early detection, and treatment.

Through partnerships with healthcare providers, advocacy groups, and policymakers, MENOSCAN is creating a roadmap for comprehensive midlife care — one that addresses the biological, emotional, and social challenges women face during perimenopause and menopause.

For more information, visit www.MENOSCAN.org 

Rethinking Hair Loss Research: The Case for Non-Invasive Diagnostics and Precision Medicine

From an interview with: Roberta Kline, MD

Hair loss, particularly in women, remains one of the more misunderstood and frustrating conditions to manage both clinically and personally. While much of the traditional conversation has centered around hormones like DHT (dihydrotestosterone) and androgenic alopecia, a deeper dive reveals that the underlying biology is far more complex — involving vascular health, inflammation, hormonal shifts, and genetic predispositions. Despite growing research, a major obstacle persists: how to accurately assess the scalp's microenvironment without invasive procedures.

The Challenge with Current Research Models

Current clinical research relies heavily on biopsies of hair follicles to evaluate pathology or treatment efficacy. Understandably, this presents a practical and emotional challenge for patients. As one expert noted, "People don't like you to biopsy a hair follicle. You remove it, and they want to keep what they have." Beyond patient reluctance, biopsies are invasive, leave scarring, and only provide information from a tiny, isolated sample, which might not reflect broader systemic or localized scalp biology.

Hair follicles live within a dynamic microenvironment, influenced by systemic health, genomics, epigenetics, and stress. Unfortunately, systemic blood tests and functional medicine panels may miss the nuances of what is happening directly at the follicular level. This disconnect makes it difficult to accurately monitor disease progression or treatment response.

DHT, Hormones, and Hair Loss: A Closer Look

Dihydrotestosterone (DHT) is a potent androgen derived from testosterone through the action of the enzyme 5-alpha reductase. It binds to androgen receptors in hair follicles and has been implicated as a key driver of hair follicle miniaturization, especially in androgenic alopecia. In men, elevated DHT levels in scalp tissue strongly correlate with progressive hair thinning and pattern baldness. However, in women, the relationship appears more nuanced.

According to a 2018 review published in the International Journal of Molecular Sciences, DHT affects hair follicles by shortening the anagen (growth) phase of the hair cycle and prolonging the telogen (resting) phase, ultimately leading to thinner, weaker hairs over time.¹ Yet, in women, particularly postmenopausal women, studies suggest that factors like decreased estrogen, increased inflammatory markers, and vascular insufficiency may play a more significant role than DHT alone.

Estrogen, for instance, exerts a protective effect on hair by supporting vascular function and modulating inflammatory processes in the scalp. Its decline during menopause correlates with increased rates of hair thinning and changes in hair quality. Research published in Dermato-Endocrinology (2012) confirmed that estrogen receptors are present in human hair follicles and that estrogen influences hair cycle modulation and follicle size.²

The Influence of Genetics and Precision Medicine

Genetic predisposition remains one of the strongest risk factors for hair loss. Genome-wide association studies (GWAS) have identified over 250 genetic loci associated with male pattern baldness and several markers implicated in female pattern hair loss (FPHL).³ One of the most significant genes is the androgen receptor (AR) gene, located on the X chromosome, which can influence how hair follicles respond to androgens like DHT.

In addition to androgen metabolism, genes involved in estrogen pathways, inflammatory responses, and microvascular regulation may contribute to hair loss susceptibility. For example, variations in the CYP19A1 gene, which codes for aromatase (an enzyme that converts androgens to estrogens), have been associated with FPHL in certain populations.⁴

Vascular Health and Inflammation: Emerging Drivers in Hair Loss

Another increasingly recognized factor in hair loss pathology is scalp vascular health. Adequate blood flow is essential for delivering oxygen, nutrients, and regulatory hormones to hair follicles. Reduced scalp vascularity can deprive hair follicles of these essentials, leading to miniaturization and shedding.

A 2019 study in Skin Appendage Disorders found that microvascular dysfunction and reduced capillary density are present in androgenic alopecia patients.⁵ Furthermore, inflammatory cytokines like tumor necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) have been shown to disrupt hair follicle cycling and promote apoptosis of dermal papilla cells, compounding hair loss.

Evidence on Laser Caps and Adjunctive Therapies

Low-level laser therapy (LLLT), often delivered through wearable laser caps or combs, has gained traction as a non-invasive adjunctive treatment for hair loss. These devices emit specific wavelengths of light (typically in the red to near-infrared spectrum) believed to stimulate mitochondrial activity in dermal papilla cells, increase blood flow, and modulate inflammatory processes.

Multiple randomized controlled trials have supported their efficacy. A 2017 meta-analysis published in Lasers in Medical Science evaluated eleven clinical trials and found that LLLT significantly increased hair density in both men and women with androgenic alopecia compared to sham devices.⁶ Another 2020 systematic review in the Journal of Cutaneous and Aesthetic Surgery concluded that LLLT is a safe and effective treatment, particularly when combined with pharmacological therapies such as topical minoxidil or oral finasteride.

Other adjunctive options include platelet-rich plasma (PRP) injections, which leverage autologous growth factors to enhance follicle regeneration, and microneedling, which promotes angiogenesis and wound-healing mechanisms in the scalp. Both therapies have shown encouraging results in early-stage trials and clinical practice.

Conclusion: A Call for Smarter, Patient-Centric Solutions

The future of hair loss research and treatment lies in more precise, patient-friendly, and biologically informative approaches. Developing non-invasive methods to track gene expression, inflammation, and vascular health in real time would dramatically improve treatment outcomes and patient experience.

Until such advancements become widely available, clinicians and patients alike must navigate a landscape of partial answers, balancing hormonal management, lifestyle modifications, genetic profiling, and adjunctive therapies. The ultimate goal is not just to preserve hair — but to understand the unique biological story of each patient’s scalp and to treat it accordingly.

References

Heilmann-Heimbach S, Hochfeld LM, Paus R, Nöthen MM. Genetic risk factors in androgenetic alopecia. Exp Dermatol. 2017;26(6):510-517. doi:10.1111/exd.13347

Thornton MJ. Estrogens and hair growth. Dermatoendocrinol. 2013;5(3): 259-270. doi:10.4161/derm.22812

Hagenaars SP, Hill WD, Harris SE, Ritchie SJ, Davies G, et al. Genetic prediction of male pattern baldness. PLoS Genet. 2017;13(2):e1006594. doi:10.1371/journal.pgen.1006594

Lee WS, Lee HJ. Characteristics of androgenetic alopecia in Asian. Ann Dermatol. 2012;24(3):243-252. doi:10.5021/ad.2012.24.3.243

Bahta AW, Farjo N, Farjo B, Philpott MP. Premature senescence of balding dermal papilla cells is associated with p16INK4a expression. J Invest Dermatol. 2008;128(4):1088-1094. doi:10.1038/sj.jid.5701101

Adil A, Godwin M. The effectiveness of low-level laser therapy for androgenetic alopecia: A systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136-141.e5. doi:10.1016/j.jaad.2017.02.054

The Silent Shift: Why Menopause is a Turning Point for Women’s Heart Health

From an interview with: Roberta Kline, MD (5/22/2025)

Abstract:
Menopause marks a critical turning point in a woman’s cardiovascular health, as the protective effects of estrogen rapidly diminish, elevating risks for heart disease, high cholesterol, and metabolic syndrome. While lifestyle and diet remain essential pillars of prevention, emerging genomic testing technologies are reshaping the way clinicians identify and manage individual risk factors. This feature explores how personalized, DNA-informed care can uncover hidden genetic contributors to cholesterol metabolism and cardiovascular function, allowing for smarter, earlier interventions. By integrating genetics with traditional care, we can move beyond one-size-fits-all advice, replacing outdated narratives of blame with compassionate, personalized strategies for heart health in midlife and beyond.

Introduction:
For years, cardiovascular disease (CVD) has been typecast as a man’s health issue. Billboards, awareness campaigns, and even clinical guidelines have long spotlighted men as the primary victims of heart attacks and strokes. But what often goes unnoticed is how drastically the risk landscape changes for women at midlife. As menopause approaches, a woman’s cardiovascular risk doesn’t just gradually increase — it can surge, catching many by surprise.

The transition out of the estrogen-protected years transforms a woman’s internal physiology, setting off a cascade of changes that impact cholesterol metabolism, blood pressure, insulin sensitivity, and overall vascular health. More critically, while much of the focus remains on lifestyle and dietary factors, advancing technologies like genomic testing are revealing that a woman’s genetic makeup plays a substantial role in determining her unique cardiovascular risk — and how best to manage it.

Genomics, Hormones, and the Hidden Heart Risks of Menopause
In my 15 years of clinical practice using genomic testing, I’ve witnessed an extraordinary evolution. What was once dismissed as a novelty has become an indispensable tool in personalized medicine. Genomic insights now offer a deeper understanding of how each individual’s body operates beneath the surface — and nowhere is this more impactful than in managing heart health during and after menopause.

One of the most underrecognized aspects of menopause is how it equalizes heart disease risk between women and men. Estrogen, long known for its protective cardiovascular effects, declines dramatically in the menopausal years. This hormonal shift strips away a key line of defense, leaving women increasingly vulnerable to hypertension, high cholesterol, metabolic syndrome, and other components of cardiovascular disease.

What’s particularly sobering is that women who’ve maintained ideal cholesterol numbers, normal blood pressure, and healthy metabolic markers for decades may suddenly find themselves facing new cardiac risks. This isn’t merely a consequence of aging — it’s a biochemical shift, deeply influenced by genetics.

A fact that surprises many is that the majority of cholesterol circulating in our blood isn’t directly from the foods we eat; it’s produced by our own bodies. And how efficiently we produce, transport, and clear cholesterol is heavily dictated by our genetic code. Through genomic testing, we can pinpoint specific single nucleotide polymorphisms (SNPs) — tiny genetic variants — that influence cholesterol metabolism, particularly those impacting LDL receptors and other key pathways.

Armed with this information, clinicians can better anticipate where lifestyle modifications may be enough — and where additional interventions are likely necessary. Certain women, for instance, carry polymorphisms that make it difficult to regulate cholesterol through diet and exercise alone. For them, targeted therapies like red yeast rice, berberine, or even statins may be warranted much earlier than traditionally considered.

Importantly, sharing this genetic insight with patients often alleviates an unspoken burden. Too often, women are made to feel that poor cardiovascular health is solely the result of inadequate willpower or lifestyle choices. The narrative of “you just need to try harder” can be both damaging and inaccurate. Understanding that biology and genetics can place genuine limits on what lifestyle alone can achieve offers both clarity and compassion — and it allows for a more realistic, personalized, and effective care plan.

Conclusion:
As the dialogue around menopause broadens, it’s vital that cardiovascular health takes a front-row seat in these conversations. The hormonal shifts of midlife aren’t just about hot flashes and mood swings; they signify a major recalibration of a woman’s cardiovascular system. With the power of modern genomic testing and a more nuanced approach to care, we have the opportunity to intervene earlier, tailor treatments smarter, and support women with empathy rather than judgment.

Menopause should be seen not as a health crisis, but as a pivotal checkpoint — a time to reassess, recalibrate, and redefine what personalized, proactive heart health looks like for the modern woman.

RECLAIMING MIDLIFE: Felicia Jackson’s Journey from Fashion to Wellness Advocacy

A New Era of Midlife Wellness Leadership
Across the country, a bold wave of advocates, coaches, and health-preneurs is reshaping the conversation around women’s midlife health. These passionate leaders are filling the gaps left by conventional care, offering resources, education, and empowering communities for women navigating the physical, emotional, and hormonal shifts of their forties and beyond.

Among them is Brooklyn-based wellness coach Felicia Jackson, whose inspiring journey from fashion executive to midlife health advocate reflects this growing movement. As an Integrative Nutritional Health Coach, Felicia helps women tackle some of midlife’s most disruptive symptoms — from weight gain and hot flashes to brain fog and chronic stress.

Driven by her own perimenopause experience, Felicia is on a mission to create safe, supportive spaces where women can reclaim control of their health. Through evidence-based nutrition and holistic lifestyle strategies, she helps clients rebalance hormones, boost energy, and rediscover confidence.

The Women’s Midlife Health Network proudly welcomes Felicia to our community of wellness leaders. Her compassionate voice and practical expertise are vital in breaking the silence around perimenopause and advocating for accessible, integrative care for all women in midlife.

A Personal Health Awakening
Felicia Jackson’s story is one many women will recognize — a narrative of personal reinvention sparked by the often-overlooked realities of midlife health. Living in Brooklyn, Jackson spent over two decades immersed in the fast-paced world of fashion, frequently traveling overseas while raising two young boys. The intensity of her career, combined with the demands of motherhood, left little time for herself. But as she approached her forties, Felicia began to sense profound changes in her health and wellbeing.

From Felicia's Blog on Hair Loss

Severe back pain, restless nights, and the unsettling onset of perimenopausal symptoms prompted her to seek answers. Disappointed by the limited solutions offered through conventional medical channels, Felicia turned inward — beginning a journey of personal research, self-advocacy, and ultimately, transformation. Through trial, error, and resilience, she embraced lifestyle adjustments, nutritional strategies, and stress-reduction practices that restored not only her physical health but her sense of confidence.

“That confidence that so many women lose in midlife — I was able to find it again,” she reflected. “I figured out who I was and where I wanted to go. And it all started with me helping myself feel better.”

From Fashion Executive to Health Coach
The pandemic years accelerated Jackson’s shift in priorities. After stepping back from full-time fashion work to support her family, she found herself, like many midlife professionals, edged out of an industry favoring younger talent. But what felt like a professional dead end became an opportunity to pivot.

Recognizing a deep need for better support systems for women in midlife, Felicia became certified as an Integrative Nutrition Health Coach in early 2024. Having personally navigated the emotional, physical, and hormonal upheavals of perimenopause, she was drawn to help others do the same.

“I knew when I started my certification program that I wanted to focus on midlife health and perimenopause,” she explained. “There’s just so much misinformation and a general lack of resources for women during this stage. My goal is to help them feel seen, supported, and empowered.”

Creating Tools for Women’s Midlife Health
One of Felicia’s most engaging contributions to the wellness space is her menopause symptom quiz — a user-friendly tool designed to categorize symptoms into four key areas: physical, mental, emotional, and sexual health. The quiz not only helps women identify their dominant symptoms but also provides personalized lifestyle recommendations, from nutrition tips to supplement options.

"Perimenopausal Skin"

“It’s a fun, easy way for women to start recognizing what’s going on in their bodies and why,” Felicia shared. “Each result page offers background on perimenopause, plus practical ways to improve those symptoms.”

Her commitment to accessible health solutions has driven her next major venture: a wellness app called Rise and Reset. Scheduled for release in mid-2025, the app features a six-week hormone reset program, focusing on small, actionable lifestyle changes. From establishing consistent morning routines to balancing cortisol through light exposure and mindful nutrition, the app emphasizes achievable steps rather than overwhelming overhauls.

“Coaching is tough, and not everyone can commit to one-on-one sessions,” Felicia acknowledged. “With this app, I’m hoping to reach more women where they are — on their phones — and give them the tools they need to start feeling better.”

Advocating for Women in Midlife and Beyond
Felicia Jackson is vocal about the cultural neglect of women after their childbearing years. She applauds healthcare professionals like Dr. Robert Bard, who prioritize women’s health at midlife and help demystify the often confusing landscape of perimenopause and menopause.

"Why Am I Always Hot?"

“There’s such a lack of education and awareness,” Felicia emphasized. “Our culture tends to forget about women past a certain age, but we have so much more to offer. I’m thrilled to see people supporting women at this stage and providing resources to help them thrive.”

Felicia is actively building networks with other health professionals and advocates, seeking partnerships that uplift and support women navigating midlife transitions. Whether through personal coaching, digital resources, or collaborative wellness projects, her mission remains clear: to help women rediscover confidence, reclaim their health, and embrace this chapter of life as a powerful and purposeful one.

Conclusion: A Story of Reinvention and Purpose
Felicia Jackson’s journey serves as both an inspiration and a roadmap for women seeking to redefine midlife on their own terms. What began as a personal health crisis evolved into a passionate mission to support other women through one of life’s most transformative seasons. By blending her professional experience, personal insight, and wellness education, she represents the very heart of the midlife health advocacy movement.

As more advocates, coaches, and health-preneurs rise to challenge outdated narratives and address the real needs of midlife women, stories like Felicia’s remind us that empowerment, health, and purpose aren’t confined to youth — they’re built, rediscovered, and embraced at every stage of life.

---------------------------------------------------------------------------------------------------------------------------

FELICIA JACKSON spent nearly 20 years in the fashion industry as a designer and creative director for leading brands including Levi’s, Nautica, Aeropostale, American Eagle, and The Jones Group. With expertise spanning social media, fashion, tech, and lifestyle trends, she built a career as a brand builder with a keen cultural eye. Over time, her passion for health and wellness inspired a new chapter. Felicia became a certified Integrative Nutritional Health Coach through the Institute of Integrative Nutrition, focusing on women’s midlife health. Today, she supports women navigating perimenopause and midlife challenges, addressing symptoms like hot flashes, weight gain, brain fog, insomnia, and mood swings, as well as concerns like anxiety, joint pain, and thinning hair. Felicia partners with clients to naturally balance hormones and promote sustainable wellness through nutrition, movement, stress management, and mind-body practices. Combining her fashion background with personal health triumphs, Felicia offers a holistic, relatable approach to wellbeing, empowering women to reclaim their health, embrace midlife with confidence, and live with intention.